A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
for Advanced Solid Tumor
13 locations incl. Duarte
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06172478·Phase 2·Recruiting
Lung oncology Clinical Trials in St Louis, MO
As of June 2026, 60 paid clinical trials are recruiting for Lung oncology in St Louis, Missouri. Lung oncology trials investigate EGFR, ALK, KRAS, and other driver-mutation targeted therapies alongside immunotherapy combinations for non-small cell, small cell, and mesothelioma studies. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
60 clinical trials for Lung oncology
·Clear filters·↓ Download CSVA Study of KK2269 in Adult Participants With Solid Tumors
for Advanced Solid Tumor
7 locations incl. Scottsdale
Sponsor: Kyowa Kirin Co., Ltd.
Sex: All·Age: 18+
Code: NCT06266299·Phase 1·Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
for Advanced Solid Tumor
10 locations incl. Denver
Sponsor: BeOne Medicines
Sex: All·Age: 18+
Code: NCT06120283·Phase 1·Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
for Non-Small Cell Lung Cancer
Drug: Ivonescimab
76 locations incl. Phoenix
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT05899608·Phase 3·Recruiting
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
for Malignant Peritoneal Mesothelioma
13 locations incl. Chicago
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All·Age: 18+
Code: NCT06057935·Phase 2·Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
for Non-small Cell Lung Cancer
10 locations incl. Gilbert
Sponsor: Institut de Recherches Internationales Servier
Sex: All·Age: 18+
Code: NCT05786924·Phase 1, Phase 2·Recruiting
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
for Carcinoma, Non-small-Cell Lung
Drug: Amivantamab
26 locations incl. La Jolla
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05498428·Phase 2·Recruiting
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
for Small Cell Lung Cancer
5 locations incl. Birmingham
Sponsor: Advenchen Pharmaceuticals, LLC.
Sex: All·Age: 18+
Code: NCT05363280·Phase 2·Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
for Locally Advanced or Metastatic Solid Tumors
11 locations incl. San Francisco
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT05581004·Phase 1·Recruiting
GEMINI-NSCLC: NSCLC Biomarker Study
for Non-Small Cell Lung Cancer
58 locations incl. Birmingham
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT05236114·Recruiting
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
for NSCLC
21 locations incl. Davis
Sponsor: Lung Cancer Mutation Consortium
Sex: All·Age: All ages
Code: NCT04712877·Recruiting
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
for Advanced Solid Tumor
11 locations incl. Miami
Sponsor: Aulos Bioscience, Inc.
Sex: All·Age: 18+
Code: NCT05267626·Phase 1, Phase 2·Recruiting
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for Non Small Cell Lung Cancer
Drug: Telisotuzumab Vedotin
50 locations incl. Birmingham
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT04928846·Phase 3·Recruiting
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
for Solid Tumor, Adult
16 locations incl. Gilbert
Sponsor: A2 Biotherapeutics Inc.
Sex: All·Age: 18+
Code: NCT04981119·Recruiting
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer
38 locations incl. Duarte
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT04302025·Phase 2·Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
for Lung Non-Small Cell Carcinoma
1150 locations incl. Anchorage
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT04267848·Phase 3·Recruiting
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
for NSCLC
18 locations incl. Birmingham
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT04077099·Phase 1, Phase 2·Recruiting
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
for Healthy Volunteer
1 location in St Louis
Sponsor: Washington University School of Medicine
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT04354064·Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
for Advanced/Metastatic Solid Tumors
23 locations incl. La Jolla
Sponsor: Merus B.V.
Sex: All·Age: 18+
Code: NCT03526835·Phase 1, Phase 2·Recruiting
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for Cancer, Metastatic
67 locations incl. Birmingham
Sponsor: Massive Bio, Inc.
Sex: All·Age: All ages
Code: NCT03452774·Recruiting